{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T09:10:33Z","timestamp":1726477833258},"reference-count":28,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,7,19]],"date-time":"2007-07-19T00:00:00Z","timestamp":1184803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropathology"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:p>Although cancer is rare in children, primary brain tumors constitute the most frequent location of solid tumors in childhood. Primitive neuroectodermal tumors (PNET) of the central nervous system can be divided into infratentorial PNET or medulloblastoma (MB), and supratentorial (sPNET) tumors. Although MB and sPNET are histologically similar, clinical evolution differs, sPNET being more aggressive than MB. Some studies have suggested that MB and sPNET present different molecular genetic aberrations. The RASSF1A (Ras Association Domain Family Protein 1) gene, located at 3p21.3, is highly methylated in multiple primary tumor samples, including neuroblastoma. In order to define whether there are genetic differences in the methylation frequency of RASSF1A between MB and sPNET, we analyzed 32 PNET paraffin\u2010embedded samples (23\u2003MB and 9 sPNET) by methylation specific polymerase chain reaction (MSP). We also analyzed RASSF1A expression by reverse transcription polymerase chain reaction in five PNET cell lines. All PNET cell lines showed lack of RASSF1A expression that was correlated with RASSF1A promoter hypermethylation. RASSF1A methylation was detected in 19 of 21\u2003MB cases (91%) and in five of six sPNET samples (83%). Although the methylation frequency found in MB was slightly higher than in sPNET, no statistical differences were found for the RASSF1A hypermethylation frequency (<jats:italic>P<\/jats:italic>\u2003&gt;\u20030.05) presented at MB versus sPNET. Therefore, the inactivation of the RASSF1A gene seems to be an important step in the tumorigenesis of PNET of the central nervous sytem. More studies should be performed in order to determine genetic differences between MB and sPNET.<\/jats:p>","DOI":"10.1111\/j.1440-1789.2007.00788.x","type":"journal-article","created":{"date-parts":[[2007,7,19]],"date-time":"2007-07-19T17:12:11Z","timestamp":1184865131000},"page":"341-346","source":"Crossref","is-referenced-by-count":14,"title":["RASSF1A promoter is highly methylated in primitive neuroectodermal tumors of the central nervous system"],"prefix":"10.1111","volume":"27","author":[{"given":"Mar\u00eda\u2010del\u2010Mar","family":"Inda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier S","family":"Castresana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,7,19]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6690525"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<331::AID-CNCR18>3.0.CO;2-#"},{"key":"e_1_2_6_4_2","first-page":"1341","article-title":"PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors","volume":"12","author":"Inda MM","year":"2004","journal-title":"Oncol Rep"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8619(18)31005-3"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/77083"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204469"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204175"},{"key":"e_1_2_6_9_2","first-page":"3877","article-title":"High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma","volume":"61","author":"Lo KW","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.9.691"},{"key":"e_1_2_6_11_2","first-page":"7277","article-title":"Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma","volume":"61","author":"Morrissey C","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204968"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1331"},{"key":"e_1_2_6_14_2","first-page":"5906","article-title":"Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development","volume":"62","author":"Lusher ME","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209137"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2005.09.004"},{"key":"e_1_2_6_17_2","first-page":"667","article-title":"PTEN, DMBT1, and p16 alterations in diffusely infiltrating astrocytomas","volume":"21","author":"Fan X","year":"2002","journal-title":"Int J Oncol"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/18.11.1427"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205890"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205651"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/62.11.1192"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02893403"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204613"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1052>3.0.CO;2-S"},{"key":"e_1_2_6_25_2","first-page":"6688","article-title":"Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma","volume":"61","author":"Lee MG","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205814"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207082"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205446"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-4088"}],"container-title":["Neuropathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1789.2007.00788.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1789.2007.00788.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:44:27Z","timestamp":1696866267000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1789.2007.00788.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,19]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1111\/j.1440-1789.2007.00788.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1789.2007.00788.x","archive":["Portico"],"relation":{},"ISSN":["0919-6544","1440-1789"],"issn-type":[{"value":"0919-6544","type":"print"},{"value":"1440-1789","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,19]]}}}